Francesca Saba

1.3k total citations
31 papers, 970 citations indexed

About

Francesca Saba is a scholar working on Epidemiology, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Francesca Saba has authored 31 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 9 papers in Endocrinology, Diabetes and Metabolism and 7 papers in Molecular Biology. Recurrent topics in Francesca Saba's work include Liver Disease Diagnosis and Treatment (19 papers), Diet, Metabolism, and Disease (6 papers) and Diet and metabolism studies (3 papers). Francesca Saba is often cited by papers focused on Liver Disease Diagnosis and Treatment (19 papers), Diet, Metabolism, and Disease (6 papers) and Diet and metabolism studies (3 papers). Francesca Saba collaborates with scholars based in Italy, Australia and Belarus. Francesca Saba's co-authors include Maurizio Cassader, Roberto Gambino, Giovanni Musso, Silvia Pinach, S. Cohney, Franco De Michieli, Valeria Sogos, Chiara Rosso, Simona Bo and Elisabetta Bugianesi and has published in prestigious journals such as American Journal of Clinical Nutrition, Hepatology and Diabetes Care.

In The Last Decade

Francesca Saba

27 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Francesca Saba Italy 18 466 321 243 165 164 31 970
Fen Xu China 21 515 1.1× 418 1.3× 486 2.0× 76 0.5× 414 2.5× 76 1.4k
Javier Vargas‐Castrillón Spain 10 980 2.1× 327 1.0× 397 1.6× 150 0.9× 186 1.1× 13 1.3k
Mohamed Asrih Switzerland 15 532 1.1× 350 1.1× 355 1.5× 74 0.4× 314 1.9× 23 1.1k
Xuping Yang China 14 150 0.3× 212 0.7× 285 1.2× 73 0.4× 136 0.8× 36 667
Anissa Igoudjil France 11 736 1.6× 290 0.9× 541 2.2× 160 1.0× 341 2.1× 12 1.4k
Fareeba Sheedfar Netherlands 11 327 0.7× 110 0.3× 252 1.0× 54 0.3× 262 1.6× 14 700
Sun‐O Ka South Korea 18 244 0.5× 122 0.4× 498 2.0× 38 0.2× 189 1.2× 22 1.0k
Sanshiro Tateya United States 14 397 0.9× 161 0.5× 391 1.6× 43 0.3× 404 2.5× 17 1.2k
Samjhana Thapaliya United States 12 767 1.6× 145 0.5× 383 1.6× 380 2.3× 755 4.6× 21 1.5k
Cynthia Lebeaupin France 14 993 2.1× 249 0.8× 600 2.5× 207 1.3× 189 1.2× 18 1.7k

Countries citing papers authored by Francesca Saba

Since Specialization
Citations

This map shows the geographic impact of Francesca Saba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesca Saba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesca Saba more than expected).

Fields of papers citing papers by Francesca Saba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Francesca Saba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesca Saba. The network helps show where Francesca Saba may publish in the future.

Co-authorship network of co-authors of Francesca Saba

This figure shows the co-authorship network connecting the top 25 collaborators of Francesca Saba. A scholar is included among the top collaborators of Francesca Saba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesca Saba. Francesca Saba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Rosso, Chiara, Gian Paolo Caviglia, Angelo Armandi, et al.. (2024). Response to a 6-month personalized dietary intervention in patients with metabolic dysfunction-associated steatotic liver disease. Digestive and Liver Disease. 56. S55–S55.
4.
Musso, Giovanni, Silvia Pinach, Francesca Saba, et al.. (2024). Endoscopic duodenal mucosa ablation techniques for diabetes and nonalcoholic fatty liver disease: A systematic review. Med. 5(7). 735–758.e2. 2 indexed citations
5.
Caviglia, Gian Paolo, Chiara Rosso, Francesca Saba, et al.. (2024). Chrononutrition as a dietary strategy to reduce hepatic steatotis in patients with metabolic dysfunction-associated steatotic liver disease. Digestive and Liver Disease. 56. S49–S49. 1 indexed citations
6.
Saba, Francesca, et al.. (2023). Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease. Nutrients. 15(24). 5053–5053. 22 indexed citations
7.
Musso, Giovanni, Francesca Saba, Maurizio Cassader, & Roberto Gambino. (2023). Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances. Progress in Lipid Research. 91. 101238–101238. 31 indexed citations
8.
Demasi, Sonia, Francesca Saba, Rosalba Rosato, et al.. (2021). Compositional Characteristics and Antioxidant Activity of Edible Rose Flowers and Their Effect on Phenolic Urinary Excretion. Polish Journal of Food and Nutrition Sciences. 383–392. 4 indexed citations
9.
Felicetti, Francesco, Federica Dal Bello, Filippo Gatti, et al.. (2021). Advanced glycation end products and their related signaling cascades in adult survivors of childhood Hodgkin lymphoma: A possible role in the onset of late complications. Free Radical Biology and Medicine. 178. 76–82. 7 indexed citations
10.
Musso, Giovanni, Antonio Sircana, Francesca Saba, Maurizio Cassader, & Roberto Gambino. (2020). Assessing the risk of ketoacidosis due to sodium-glucose cotransporter (SGLT)-2 inhibitors in patients with type 1 diabetes: A meta-analysis and meta-regression. PLoS Medicine. 17(12). e1003461–e1003461. 39 indexed citations
11.
Musso, Giovanni, Francesca Saba, Maurizio Cassader, & Roberto Gambino. (2020). Diabetic ketoacidosis with SGLT2 inhibitors. BMJ. 371. m4147–m4147. 56 indexed citations
12.
Bo, Simona, Valentina Ponzo, Andrea Evangelista, et al.. (2017). Effects of 6 months of resveratrol versus placebo on pentraxin 3 in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial. Acta Diabetologica. 54(5). 499–507. 22 indexed citations
13.
Musso, Giovanni, Maurizio Cassader, Silvia Pinach, et al.. (2017). TM6SF2 rs58542926 variant affects postprandial lipoprotein metabolism and glucose homeostasis in NAFLD. Journal of Lipid Research. 58(6). 1221–1229. 42 indexed citations
14.
Bo, Simona, Valentina Ponzo, Giovannino Ciccone, et al.. (2016). Six months of resveratrol supplementation has no measurable effect in type 2 diabetic patients. A randomized, double blind, placebo-controlled trial. Pharmacological Research. 111. 896–905. 126 indexed citations
15.
Musso, Giovanni, Maurizio Cassader, Franco De Michieli, et al.. (2016). MERTK rs4374383 variant predicts incident nonalcoholic fatty liver disease and diabetes: role of mononuclear cell activation and adipokine response to dietary fat. Human Molecular Genetics. 26(9). 1747–1758. 23 indexed citations
16.
Musso, Giovanni, Maurizio Cassader, S. Cohney, et al.. (2015). Emerging Liver–Kidney Interactions in Nonalcoholic Fatty Liver Disease. Trends in Molecular Medicine. 21(10). 645–662. 94 indexed citations
17.
Gastaldelli, Amalia, Melania Gaggini, L. Mezzabotta, et al.. (2013). Alteration in lipid metabolism after an oral fat load in subjects with NAFLD.. Diabetologia. 56. 2 indexed citations
18.
Falchi, Angela Maria, Valeria Sogos, Francesca Saba, et al.. (2012). Astrocytes shed large membrane vesicles that contain mitochondria, lipid droplets and ATP. Histochemistry and Cell Biology. 139(2). 221–231. 90 indexed citations
19.
Musso, Giovanni, Maurizio Cassader, Franco De Michieli, et al.. (2011). Effect of lectin-like oxidized LDL receptor-1 polymorphism on liver disease, glucose homeostasis, and postprandial lipoprotein metabolism in nonalcoholic steatohepatitis. American Journal of Clinical Nutrition. 94(4). 1033–1042. 19 indexed citations
20.
Reali, Camilla, et al.. (2011). S100B modulates growth factors and costimulatory molecules expression in cultured human astrocytes. Journal of Neuroimmunology. 243(1-2). 95–99. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fen Xu Breakdown of academic impact, for papers by Javier Vargas‐Castrillón Breakdown of academic impact, for papers by Mohamed Asrih Breakdown of academic impact, for papers by Xuping Yang Breakdown of academic impact, for papers by Anissa Igoudjil Breakdown of academic impact, for papers by Fareeba Sheedfar Breakdown of academic impact, for papers by Sun‐O Ka Breakdown of academic impact, for papers by Sanshiro Tateya Breakdown of academic impact, for papers by Samjhana Thapaliya Breakdown of academic impact, for papers by Cynthia Lebeaupin
Rankless by CCL
2026